Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinrich Roder

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Mabs|September 5, 2015
Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approachAndreas Lehmann, Josephine H F Wixted, Maxim V Shapovalov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503Joseph M Amann, Ju-Whei Lee, Heinrich Roder, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2020
Energetics and kinetics of substrate analog-coupled staphylococcal nuclease folding revealed by a statistical mechanical approachTakuya Mizukami, Shunta Furuzawa, Satoru G Itoh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Current Biology : CB|May 31, 2016
H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 HeterodimerizationSonali J Rawat, Daniela Araiza-Olivera, Luis E Arias-Romero, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|November 25, 2021
A proposal for score assignment to characterize biological processes from mass spectral analysis of serumJoanna Roder, Lelia Net, Carlos Oliveira, et al.
International Journal of Medical Informatics|October 3, 2021
Predicting prognosis in COVID-19 patients using machine learning and readily available clinical dataThomas W Campbell, Melissa P Wilson, Heinrich Roder, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2018
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapyFrancesco Grossi, Carlo Genova, Erika Rijavec, et al.
The Journal of Biological Chemistry|May 8, 2015
The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in PlateletsYibing Wu, Lisa M Span, Patrik Nygren, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2007
Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activationDharmaraj Samuel, Hong Cheng, Paul W Riley, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Mabs|September 5, 2015
Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approachAndreas Lehmann, Josephine H F Wixted, Maxim V Shapovalov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503Joseph M Amann, Ju-Whei Lee, Heinrich Roder, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2020
Energetics and kinetics of substrate analog-coupled staphylococcal nuclease folding revealed by a statistical mechanical approachTakuya Mizukami, Shunta Furuzawa, Satoru G Itoh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Current Biology : CB|May 31, 2016
H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 HeterodimerizationSonali J Rawat, Daniela Araiza-Olivera, Luis E Arias-Romero, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|November 25, 2021
A proposal for score assignment to characterize biological processes from mass spectral analysis of serumJoanna Roder, Lelia Net, Carlos Oliveira, et al.
International Journal of Medical Informatics|October 3, 2021
Predicting prognosis in COVID-19 patients using machine learning and readily available clinical dataThomas W Campbell, Melissa P Wilson, Heinrich Roder, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2018
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapyFrancesco Grossi, Carlo Genova, Erika Rijavec, et al.
The Journal of Biological Chemistry|May 8, 2015
The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in PlateletsYibing Wu, Lisa M Span, Patrik Nygren, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2007
Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activationDharmaraj Samuel, Hong Cheng, Paul W Riley, et al.
Pageof 9